RBC Life Sciences Wins Top Award for its Antioxidant Product, OliViva, While Competing against a Field of National Brands
Friday November 7, 9:08 am ET
IRVING, Texas--(BUSINESS WIRE)--Some of the package industry’s leading experts have awarded RBC Life Sciences (OTCBB: RBCL - News) a first-place award for the visually appealing design of the nutritional supplements company’s newest antioxidant product, OliViva™.
packagePrinting magazine annually assembles a team of the industry’s leading experts to judge designs submitted by some of the nation’s largest brand names. The panel granted its top award for excellence this year to the label design for OliViva. It found the design to be visually appealing, that it served its intended purpose and that it exhibited superior printing technique. Previous winners have included Bacardi, Victoria’s Secret and Gillette.
“We’re honored that these prestigious industry experts recognized the beauty of OliViva’s branding,” RBC Life Sciences President John W. Price said of the drink made from freshly harvested olive leaves and other natural botanicals. “And rest assured, OliViva tastes as good as its packaging looks.”
OliViva comes in a 30-ounce glossy black bottle accented with a visually appealing neon-green accent stripe and an elegantly designed brand name. A dove was added to the design to promote the historical significance of a product based on olive leaf extract. The synergy of the imagery creates a striking package that draws the eye to the brand name.
The antioxidant drink’s branding also recently won a silver-place award presented by the Flexographic Technical Association as part of its Excellence in Flexography Awards Competition.
About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
Contact:
RBC Life Sciences
Alan Van Zelfden, 972-893-4050
alan.vanzelfden@rbclifesciences.com
or
Ann Billings, 972-893-4000
ann.billings@rbclifesciences.com
--------------------------------------------------------------------------------
Source: RBC Life Sciences
News 
Market Data 
Discover 
